Sa1086 Dose Escalation of Vedolizumab From Every 8 Weeks to Every 4 or 6 Weeks Enables Patients With Inflammatory Bowel Disease to Recapture Response
Ladd, Antonio H. Mendoza, Scott, Frank I., Grace, Rory, Bownik, Hillary, Lichtenstein, Gary R.Volume:
150
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(16)30859-9
Date:
April, 2016
File:
PDF, 828 KB
english, 2016